United States · FDA National Drug Code directory
SAVAYSA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65597-201_dc54247c-0158-4cae-b692-914717ab3a67
- Product NDC
- 65597-201
- Form
- TABLET, FILM COATED
- Composition / generic term
- EDOXABAN TOSYLATE
- Labeler
- Daiichi Sankyo Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150112
- Source listing expiry
- 20261231
Source-listed ingredients
- EDOXABAN TOSYLATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET, FILM COATED in 1 BOTTLE (65597-201-07) · 65597-201-07
- 10 TABLET, FILM COATED in 1 BLISTER PACK (65597-201-10) · 65597-201-10
- 30 TABLET, FILM COATED in 1 BOTTLE (65597-201-30) · 65597-201-30
- 500 TABLET, FILM COATED in 1 BOTTLE (65597-201-50) · 65597-201-50
- 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-201-70) · 65597-201-70
- 90 TABLET, FILM COATED in 1 BOTTLE (65597-201-90) · 65597-201-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →